Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEUROKINASE: ERK5 and PKM2 in Neuroinflammatory Diseases
NCT04674163Withdrawn
- Sponsor
- Centre Hospitalier Régional d'Orléans
- Start
- Jan 2023
- Primary completion
- Jan 2023
01
Overview
Open-label trial (3 arms), sponsored by Centre Hospitalier Régional d'Orléans. Primary endpoint: Expression of genes encoding ERK5 and PKM2 kinases by RT-qPCR at Day 0. Planned start Jan 2023; status: withdrawn.
Beyond the preview
Go deeper on NCT04674163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674163.